111 related articles for article (PubMed ID: 3499924)
21. Electrophysiological effects of sotalol--just another beta blocker?
Nathan AW; Hellestrand KJ; Bexton RS; Ward DE; Spurrell RA; Camm AJ
Br Heart J; 1982 Jun; 47(6):515-20. PubMed ID: 7082499
[TBL] [Abstract][Full Text] [Related]
22. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
Kühlkamp V; Mewis C; Mayer F; Seipel L
Z Kardiol; 1990 Oct; 79(10):725-31. PubMed ID: 2087860
[TBL] [Abstract][Full Text] [Related]
23. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
Manz M; Kuhl AJ; Lüderitz B
Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
[TBL] [Abstract][Full Text] [Related]
24. Comparative electrophysiologic profiles of calcium antagonists with particular reference to bepridil.
Singh BN; Nademanee K; Feld G; Piontek M; Schwab M
Am J Cardiol; 1985 Mar; 55(7):14C-19C. PubMed ID: 3872052
[TBL] [Abstract][Full Text] [Related]
25. Retrograde atrial preexcitation following premature ventricular beats during reciprocating tachycardia in the Wolff-Parkinson-White syndrome.
Sellers TD; Gallagher JJ; Cope GD; Tonkin AM; Wallace AG
Eur J Cardiol; 1976 Sep; 4(3):283-94. PubMed ID: 964277
[TBL] [Abstract][Full Text] [Related]
26. Electrophysiological profile of bepridil, a new anti-anginal drug with calcium blocking properties.
Flammang D; Waynberger M; Jansen FH; Paillet R; Coumel P
Eur Heart J; 1983 Sep; 4(9):657-54. PubMed ID: 6605854
[TBL] [Abstract][Full Text] [Related]
27. Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome.
Spurrell RA; Thorburn CW; Camm J; Sowton E; Deuchar DC
Br Heart J; 1975 Aug; 37(8):861-7. PubMed ID: 53057
[TBL] [Abstract][Full Text] [Related]
28. [Electrophysiologic effects of amiodarone in Wolf-Parkinson-White syndrome].
Touboul P; Porte J; Huerta F; Delahaye JP
Arch Mal Coeur Vaiss; 1976 Aug; 69(8):855-63. PubMed ID: 823923
[TBL] [Abstract][Full Text] [Related]
29. Radiofrequency current catheter ablation of accessory atrioventricular pathways.
Trajkov I; Kovacevic D; Boskov V; Poposka L; Gjorgov N
Prilozi; 2006 Dec; 27(2):71-87. PubMed ID: 17211293
[TBL] [Abstract][Full Text] [Related]
30. Invasive electrophysiologic study: its role in the pre-excitation syndromes.
Untereker WJ
Cardiovasc Clin; 1985; 16(1):97-117. PubMed ID: 3915717
[No Abstract] [Full Text] [Related]
31. Effect of tiapamil in the Wolff-Parkinson-White syndrome.
Gmeiner R; Ng CK
J Cardiovasc Pharmacol; 1981; 3(2):237-50. PubMed ID: 6166796
[TBL] [Abstract][Full Text] [Related]
32. Prolongation of QT interval and antiarrhythmic action of bepridil.
Somberg J; Torres V; Flowers D; Miura D; Butler B; Gottlieb S
Am Heart J; 1985 Jan; 109(1):19-27. PubMed ID: 3871296
[TBL] [Abstract][Full Text] [Related]
33. Effects of bepridil on conduction properties of the isolated rabbit sinus node and atrial myocardium.
Kirchhof CJ; Bonke FI; Allessie MA; Huijberts MS
J Cardiovasc Pharmacol; 1989 Jan; 13(1):131-7. PubMed ID: 2468924
[TBL] [Abstract][Full Text] [Related]
34. [Bepridil--electrophysiologic properties of a new calcium antagonist with an anti-arrhythmia effect].
Zehender M; Geibel A; Henning B; Hohnloser S; Meinertz T; Just H
Z Kardiol; 1988 Feb; 77(2):93-8. PubMed ID: 3259053
[TBL] [Abstract][Full Text] [Related]
35. [Effects of mexiletine in the Wolff-Parkinson-White syndrome].
Touboul P; Gressard A; Kirkorian G; Atallah G
Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1315-23. PubMed ID: 6797370
[TBL] [Abstract][Full Text] [Related]
36. Electrophysiological effects of lorcainide, a new antiarrhythmic drug. Observations in patients with and without pre-excitation.
Bär FW; Farré J; Ross D; Vanagt EJ; Gorgels AP; Wellens HJ
Br Heart J; 1981 Mar; 45(3):292-8. PubMed ID: 7470342
[TBL] [Abstract][Full Text] [Related]
37. Electrophysiological and electropharmacological studies in pre-excitation syndromes: results with propafenone therapy and isoproterenol infusion testing.
Manolis AS; Katsaros C; Cokkinos DV
Eur Heart J; 1992 Nov; 13(11):1489-95. PubMed ID: 1361174
[TBL] [Abstract][Full Text] [Related]
38. [Surgical atrioventricular disconnection in Wolff-Parkinson-White syndrome].
Pavie A; Mesnildrey P; Gandjbakhch I; Cabrol C; Fontaine G; Franck R; Grosgogeat Y; Slama R
Arch Mal Coeur Vaiss; 1984 Jun; 77(6):606-15. PubMed ID: 6431924
[TBL] [Abstract][Full Text] [Related]
39. Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man.
Hellestrand KJ; Bexton RS; Nathan AW; Spurrell RA; Camm AJ
Br Heart J; 1982 Aug; 48(2):140-8. PubMed ID: 7093083
[TBL] [Abstract][Full Text] [Related]
40. Diprafenone for treatment of Wolff-Parkinson-White syndrome.
Kunze KP; Schlüter M; Geiger M; Kuck KH
Cardiovasc Drugs Ther; 1989 Mar; 3(1):73-9. PubMed ID: 2487525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
